Susquehanna International Group
LABP

Susquehanna International Group’s Landos Biopharma, Inc. Common Stock LABP Stock Holding History

Susquehanna International Group’s Portfolio LABP Stock Details LABP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,498
Closed -$4.46K – 13662
2023
Q1 		$4.46K Sell
1,498
-608
-29% -$2.24K ﹤0.01% 12317
2022
Q4 		$10.5K Buy
+2,106
New +$8.06K ﹤0.01% 11933
2022
Q3 		– Sell
-1,253
Closed -$9K – 14517
2022
Q2 		$9K Buy
+1,253
New +$11.4K ﹤0.01% 12539

Other funds holding LABP

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's LABP Position: Q2 2023 in Review

Susquehanna International Group sold out of Landos Biopharma, Inc. Common Stock (LABP) in Q2 2023, closing a stake of 1,498 shares — an estimated $4.46K sold.

Susquehanna International Group first reported a position in LABP in Q2 2022 and held it in 3 quarters. The position peaked at $10.5K in Q4 2022. 8 funds tracked by Wall St. Rank hold LABP as of Q2 2023.

  • Susquehanna International Group reported no remaining Landos Biopharma, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 1,498 Landos Biopharma, Inc. Common Stock shares in Q2 2023, an estimated $4.46K.
  • Susquehanna International Group first reported a position in Landos Biopharma, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Susquehanna International Group's Landos Biopharma, Inc. Common Stock position peaked at $10.5K in Q4 2022.
  • 8 funds tracked by Wall St. Rank held Landos Biopharma, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.